Showing results (481-490 of 500) with videos related to

Sort By:
Pageof 50
Cell Host & Microbe|November 29, 2023
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterXun Wang, Shujun Jiang, Wentai Ma, et al.
Journal of Medical Virology|December 27, 2022
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodiesShibo Li, Jianbo Wu, Weiyu Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Cell Discovery|June 17, 2022
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variantMan Chun Chiu, Cun Li, Xiaojuan Liu, et al.
Cell Reports|January 24, 2021
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBDYunjiao Zhou, Zezhong Liu, Shibo Li, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2025
A branched peptide targets virus and host to block influenza virus and rhinovirus entryXinjie Meng, Chuyuan Zhang, Xiankun Wang, et al.
Signal Transduction and Targeted Therapy|November 4, 2021
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variantsZhenlin Yang, Yulu Wang, Yujia Jin, et al.
Mbio|July 20, 2021
FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal RepeatXinyi Yang, Xiaying Zhao, Yuqi Zhu, et al.
Cell Discovery|April 21, 2022
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecovirusesYingdan Wang, Meiqin Liu, Yaping Shen, et al.
Nature Communications|February 9, 2021
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamideFei Li, Ming Han, Pengfei Dai, et al.
Pageof 50